No Detail Found!

D-Dimer as Biomarker in Vaccinated Cardiovascular Disease Population During Covid 19

Author(s)
Mohammed Sarosh Khan Department of Basic Medical Sciences, College of Medicine, Prince Sattam bin Abdul Aziz University, Saudi Arabia
Md Rizwan Ansari Department of Basic Medical Sciences, College of Medicine, Prince Sattam bin Abdul Aziz University, Saudi Arabia
Md. Nadeem Bari Department of Basic Medical Sciences, College of Medicine, Prince Sattam bin AbdulAziz University, Saudi Arabia
Imran Mohammad Department of Basic Medical Sciences, College of Medicine, Prince Sattam bin AbdulAziz University, Saudi Arabia
Mohammad Anwar Shadan College of Allied Health Sciences. Hyderabad., India
Abstract
Background: COVID-19, and mRNA vaccines can raise the CVDs risk through receptor binding proteins and inflammation, specifically the ACE 2 receptor. Objective: To evaluate the significance of D-dimer and other inflammatory biomarkers in predicting CVD complications among vaccinated patients with COVID-19, along with mild, moderate and severe illness severity. Materials and Methods: Serum samples were collected at baseline, on average 7 days after onset of symptoms from 60 hospitalized COVID-19 patients (71% men, 29% female). We quantified the levels of interleukin 6(IL-6), C-reactive protein (CRP), ferritin, procalcitonin, lactate dehydrogenase (LDH) and D-dimer. Cross-sectional comparisons with COVID-19 severity, diabetes status, vaccination and SARSCoV-2 variant were made. Results: 50% of patients were diabetic and more patients with severe illness had diabetes. Levels of D-dimer were significantly higher among the diabetic patients with moderate illness than in nondiabetics (p = 0.041). In severe illness, D-dimer levels between diabetic and non-diabetic individuals were comparable (p = 0.066). High D-dimer, prothrombin time and cardiac biomarkers were positively correlated with CVD risks in COVID-19 patients, an apparent inflammatory response was highly observed by daytime temperature during COVID-19 among diabetes patients. Conclusions: This study suggests that COVID-19 and mRNA vaccinations can increase the overall risk of CVDs in patients, especially patients with diabetes by increasing inflammatory markers such as D-dimer. The various D-dimer and other biomarkers can be monitored to determine the risks associated with CVD in this population.
Publication Details
Page(s) 153-158
Published Journal: Journal of Pioneering Medical Sciences, Volume: 13, Issue: 6, Year: 2024

Request the full text from PASTIC

Keywords
COVID-19, Cardiovascular disease, vaccination, D-dimer, Covid-19, Inflammatory Biomarkers
References
Simone A,Herald J,Chen A,myocarditis Simone A,Herald J,Chen A,Gulati N,Shen AY,Lewin B,Lee MS .2021 .. 2021 Dec, 10(12) : PMC8491129-1670.
Witberg G,Barda N,Hoss S,Richter I,Wiessman M,Aviv Y,Grinberg T,Auster O,Dagan N,Balicer RD,Kornowski R . .Myocarditis after Covid-19 Vaccination in a Large Health Care Organization. 2021 Dec, 10(23) : PMC8531986-2139.
Caso F,Costa L,Ruscitti P,Navarini L,Del Puente A,Giacomelli R,Scarpa R.,Could R. .2020 .2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun Rev. , 102524(5) : PMC7271072.
Pomara C,Sessa F,Ciaccio M,Dieli F,Esposito M,Garozzo SF,Giarratano A,Prati D,Rappa F,Salerno M,Tripodo C,Zamboni P,Mannucci PM .2021 .Post-mortem findings in vaccine-induced thrombotic thombocytopenia. Haematologica. 2021 Aug, 10(8) : PMC8327725-2293.
Ma L,Song K,Huang Y.,Coronavirus Y.,Complications Cardiovascular .2020 .. J Cardiothorac Vasc Anesth, 04(6) : PMC7192093-1865.
Novak N,Tordesillas L,Cabanillas B .2021 .Adverse rare events to vaccines for COVID-19: From hypersensitivity reactions to thrombosis and thrombocytopenia. Int Rev Immunol, 1939696(4) : PMC8290371-447.
Klein NP,Lewis N,Goddard K,Fireman B,Zerbo O,Hanson KE,Donahue JG,Kharbanda EO,Naleway A,Nelson JC,Xu S,Yih WK,Glanz JM,Williams JTB,Hambidge SJ,Lewin BJ,Shimabukuro TT,DeStefano F,Weintraub ES .2021 .Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA. 2021 Oct, 10(14) : PMC8511971-1399.
Kaufmann CC,Ahmed A,Burger AL,Muthspiel M,Jäger B,Wojta J,Huber K.,Biomarkers K. . .Associated with Cardiovascular Disease in COVID-19. 2022 Mar, 10(6) : PMC8946710.
Fauci AS,Lane HC,Redfield RR . .-19 - Navigating the Uncharted. 2020 Mar, 10(13) : PMC7121221-1269.
Parasher A . .Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgrad Med, 10(1147) : PMC10017004-320.
Peeri NC,Shrestha N,Rahman MS,Zaki R,Tan Z,Bibi S,Baghbanzadeh M,Aghamohammadi N,Zhang W,Haque U.,The SARS . .MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?. Int J Epidemiol. 2020 Jun, 10(3) : PMC7197734-726.
Chung MK,Zidar DA,Bristow MR,Cameron SJ,Chan T,Harding CV,Kwon DH,Singh T,Tilton JC,Tsai EJ,Tucker NR,Barnard J,Loscalzo J,Disease Cardiovascular . .. 2021 Apr, 10(8) : PMC8048382-1236.
Brown CC,Young SG,Pro GC .2021 .COVID-19 vaccination rates vary by community vulnerability: A county-level analysis. Vaccine. 2021 Jul, 06(31) : PMC8215509-4249.
Kaur RJ,Dutta S,Bhardwaj P,Charan J,Dhingra S,Mitra P,Singh K,Yadav D,Sharma P,Misra S.,Adverse Events Reported From Vaccine,Trials A Systematic,Review. Indian J Clin Biochem A Systematic .2021 .. , 10(4) : PMC7997788-439.
Klein NP,Lewis N,Goddard K,Fireman B,Zerbo O,Hanson KE,Donahue JG,Kharbanda EO,Naleway A,Nelson JC,Xu S,Yih WK,Glanz JM,Williams JTB,Hambidge SJ,Lewin BJ,Shimabukuro TT,DeStefano F,Weintraub ES .2021 .Surveillance for Adverse Events After COVID-19 mRNA Vaccination. JAMA. 2021 Oct, 10(14) : PMC8511971-1399.
Diaz GA,Parsons GT,Gering SK,Meier AR,Hutchinson IV,Robicsek A .2021 .Myocarditis and Pericarditis After Vaccination for COVID-19. 2021 Sep, 10(12) : PMC8340007-1212.
Tavazzi G,Pellegrini C,Maurelli M,Belliato M,Sciutti F,Bottazzi A,Sepe PA,Resasco T,Camporotondo R,Bruno R,Baldanti F,Paolucci S,Pelenghi S,Iotti GA,Mojoli F,Arbustini E .1828 .Epub 2020 Apr 11. Eur J Heart Fail, 10(5) : PMC7262276-915.
Schaller T,Hirschbühl K,Burkhardt K,Braun G,Trepel M,Märkl B,Claus R. Postmortem B .2020 .Examination of Patients With COVID-19. 2020 Jun, 10(24) : PMC7243161-2520.
Ruan Q,Yang K,Wang W,Jiang L,Song J. . .Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. PMID: 32125452; PMCID: PMC7080116., 10(6) : 1294-1297.
Lindner D,Fitzek A,Bräuninger H,Aleshcheva G,Edler C,Meissner K,Scherschel K,Kirchhof P,Escher F,Schultheiss HP,Blankenberg S,Püschel K,Westermann D. .2020 .Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. 2020 Nov, 10(11) : PMC7385672-1285.
0

Citations

0

Downloads

52

Views